Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type

66Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

Abstract

Background: ABO blood type locus has been reported to be an important genetic determinant of venous and arterial thrombosis in genome-wide association studies. We tested the hypothesis that ABO blood type alone and in combination with mutations in factor V Leiden R506Q and prothrombin G20210A is associated with the risk of venous thromboembolism and myocardial infarction in the general population. Methods: We used data from 2 Danish studies that followed members of the general public from 1977 through 2010. We obtained the genotype of 66 001 white participants for ABO blood type, factor V Leiden R506Q and prothrombin G20210A. We calculated hazard ratios (HRs) and population attributable risk. Our main outcome measures were venous thromboembolism and myocardial infarction. Results: The multivariable adjusted HR for venous thromboembolism was 1.4 (95% confidence interval [CI] 1.3-1.5) for non-O blood type (v. O blood type). For the factor V Leiden R506Q mutation, the adjusted HR was 2.2 (95% CI 2.0-2.5) for heterozygous participants and 7.0 (95%CI 4.8-10) for homozygous participants (v. participants without the mutation). For prothrombin G20210A, the adjusted HR was 1.5 (95%CI 1.2-1.9) for heterozygous participants and 11 (95% CI 2.8-44) for homozygous participants (v. participants without the mutation). When we combined ABO blood type and factor V Leiden R506Q or prothrombin G20210A genotype, there was a stepwise increase in the risk of venous thromboembolism (trend, p < 0.001). The population attributable risk of venous thromboembolism was 20% for ABO blood type, 10% for factor V Leiden R506Q and 1% for prothrombin G20210A. Multivariable adjusted HRs for myocardial infarction by genotypes did not differ from 1.0. Interpretation: ABO blood type had an additive effect on the risk of venous thromboembolism when combined with factor V Leiden R506Q and prothrombin G20210A mutations; blood type was the most important risk factor for venous thromboembolism in the general population. © 2013 Canadian Medical Association or its licensors.

References Powered by Scopus

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

1753Citations
N/AReaders
Get full text

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

1091Citations
N/AReaders
Get full text

Mutation in the gene coding for coagulation factor v and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1062Citations
N/AReaders
Get full text

Cited by Powered by Scopus

ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors

136Citations
N/AReaders
Get full text

ABO blood group and thrombotic vascular disease

109Citations
N/AReaders
Get full text

Prospective study of sickle cell trait and venous thromboembolism incidence

95Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sode, B. F., Allin, K. H., Dahl, M., Gyntelberg, F., & Nordestgaard, B. G. (2013). Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ. Canadian Medical Association Journal, 185(5). https://doi.org/10.1503/cmaj.121636

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 22

61%

Researcher 7

19%

Professor / Associate Prof. 5

14%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 32

67%

Agricultural and Biological Sciences 9

19%

Biochemistry, Genetics and Molecular Bi... 4

8%

Nursing and Health Professions 3

6%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 41

Save time finding and organizing research with Mendeley

Sign up for free